Trial Profile
A single-center observational study to evaluate the long-term effectiveness of Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2017
Price :
$35
*
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Anaplastic large cell lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 24 Nov 2017 New trial record